Work

Denosumab in men with non-metastatic castration-resistant prostate cancer (CRPC) and PSA doubling time (PSADT) <= 6 months - a post-hoc analysis of a randomised trial

Year: 2013

Type: article

Authors: Siu-leung Wong, K. Miller, Mitchell R. Smith, David P. Dearnaley, L Dogliott, Blair Egerdie, Karim Fizazi, Frank Kueppers, L. Montes de, Juan Moróte, Ivan Pavlík, Paul Sieber, T. J Tammel, Hendrik Van Poppel, Manfred P. Wirth, Z Ye, Ada Braun

Language: English

Topic: Bone health and treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2523729819

FWCI:

Cites:

Cited by: 2

Related to: 10